Multicenter observational study of the efficancy of sitagliptin in patients at high risk of cardiovascular disease

Multicenter observational study of the efficancy of sitagliptin in patients at high risk of cardiovascular disease - Sitagliptin Registry Kinki Cardiologists' Study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000005663

Enrollment

500

Registered

2011-06-01

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with type 2 diabetes mellitus who failed to achieve the target blood glucose level. Additionally,patient will be included if they have more than one folloing item. hypertension dyslipidemia history of cardiovascular diseases high agesmoking obesity hyperuricemia

Exclusion criteria

Exclusion criteria: history of diabetic ketosis and coma within 6 month sepsis,before and after operation,severe injury pregnant woman,woman with chance of pregnancy dialysis patient,severe renal dysfunction hypersensitivity to the medicine a case determined inappropriate

Design outcomes

Primary

Measure	Time frame
The primary end-point is HbA1c measurement every three months for twelve months after introduction,addition or change from other drugs of sitagliptin in patinets at high risk of cardiovascular disease who failed to achieve the target blood glucose level despite diet, excise and anti-diabetic drug therapies.	—

Secondary

Measure	Time frame
Other laboratory data, cardiovascular indices and adverse events will be analyzed as well.	—

Countries

Japan

Outcome results